FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 2023749 · Received March 18, 2011

Report

Report Number
1423500-2011-03375
Event Type
Injury
Date Received
March 18, 2011
Date of Event
February 1, 2011
Report Date
February 24, 2011
Manufacturer
BAXTER HEALTHCARE
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICE INVOLVED IN THE INCIDENT WAS UNKNOWN. AS THE DATE OF ONSET OF THIS PERITONITIS EPISODE IS UNKNOWN AND PATIENTS DISCARD SUPPLIES AFTER EACH THERAPY, THE SAMPLE WAS NOT REQUESTED. A 510(K) NUMBER WILL NOT BE PROVIDED IN THE EMDR AS THE PRODUCT CODE AND LOT NUMBER ARE UNKNOWN. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. THE ROOT CAUSE INVESTIGATION IS IN PROGRESS.

Description of Event or Problem · 1

THIS REPORT WAS RECEIVED FROM GLOBAL PHARMACOVIGILANCE AND IS A SOLICITED REPORT BY A PHYSICIAN FROM (B)(6) OF STERILE PERITONITIS COINCIDENT WITH EXTRANEAL VIAFLEX THERAPY. ON AN UNREPORTED DATE, THE PATIENT BEGAN TREATMENT WITH EXTRANEAL VIAFLEX. ON (B)(6) 2011, THE PATIENT BEGAN TREATMENT WITH EXTRANEAL VIAFLEX IP FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD). ON (B)(6) 2011, THE PATIENT EXPERIENCED STERILE PERITONITIS MANIFESTED BY ABDOMINAL PAIN. ON THE SAME DAY, THE PATIENT BEGAN REMEDIAL THERAPY WITH KEFZOL (250MG, FREQUENCY NOT REPORTED, IP). ON AN UNREPORTED DATE, EXTRANEAL VIAFLEX WAS WITHDRAWN AND THE PATIENT SPECIFICALLY IMPROVED WITH THE DISCONTINUATION OF THE PRODUCT. ON (B)(6) 2011, REMEDIAL THERAPY WITH KEFZOL ENDED. ON (B)(6) 2011, THE PATIENT RECOVERED FROM THE STERILE PERITONITIS. ON AN UNREPORTED DATE, EXTRANEAL VIAFLEX WAS REINTRODUCED. THE PHYSICIAN STATED THAT THE EVENT OF STERILE PERITONITIS WAS RELATED TO THE EXTRANEAL VIAFLEX THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE

Patients

Seq Age Sex Outcome Treatment
1 35 YR Required Intervention EXTRANEAL VIAFLEX